|
US5204252A
(en)
*
|
1989-02-08 |
1993-04-20 |
Henkel Research Corporation |
Candida tropicalis transformation system
|
|
PT98310B
(pt)
*
|
1990-07-13 |
1999-01-29 |
Transkaryotic Therapies Inc |
Processo de recombinacao homologa para identificacao e isolamento dum fragmento pretendido de adn a partir de uma biblioteca de fragmentos
|
|
WO1992013951A1
(en)
*
|
1991-02-04 |
1992-08-20 |
The Salk Institute Biotechnology/Industrial Associates, Inc. |
Production of human serum albumin in methylotrophic yeast cells
|
|
US5863894A
(en)
*
|
1995-06-05 |
1999-01-26 |
Corvas International, Inc. |
Nematode-extracted anticoagulant protein
|
|
US5872098A
(en)
*
|
1995-06-05 |
1999-02-16 |
Corvas International, Inc. |
Nematode-extracted anticoagulant protein
|
|
US5866542A
(en)
*
|
1994-10-18 |
1999-02-02 |
Corvas International, Inc. |
Nematode-extracted anticoagulant protein
|
|
US5866543A
(en)
*
|
1995-06-05 |
1999-02-02 |
Corvas International, Inc. |
Nematode-extracted anticoagulant protein
|
|
CA2202351A1
(en)
*
|
1994-10-18 |
1996-04-25 |
George Phillip Vlasuk |
Nematode-extracted serine protease inhibitors and anticoagulant proteins
|
|
HU225126B1
(en)
*
|
1994-10-18 |
2006-06-28 |
Dendreon Corp |
Nematode-extracted serine protease inhibitors and anticoagulant proteins
|
|
US5945275A
(en)
*
|
1994-10-18 |
1999-08-31 |
Corvas International, Inc. |
Nematode-extracted anticoagulant protein
|
|
MX9605082A
(es)
|
1996-10-24 |
1998-04-30 |
Univ Autonoma De Nuevo Leon |
Levaduras metilotroficas modificadas geneticamente para la produccion y secrecion de hormona de crecimiento humano.
|
|
WO2000071713A1
(en)
|
1999-05-20 |
2000-11-30 |
Scios Inc. |
Vascular endothelial growth factor variants
|
|
WO2000071716A2
(en)
*
|
1999-05-20 |
2000-11-30 |
Scios Inc. |
Vascular endothelial growth factor dimers
|
|
US6261820B1
(en)
*
|
1999-10-01 |
2001-07-17 |
Amgen Inc. |
Fibronolytically active polypeptide
|
|
US6440414B1
(en)
*
|
1999-10-01 |
2002-08-27 |
Amgen Inc. |
Pharmaceutical compositions of fibrinolytic agent
|
|
US7033776B2
(en)
*
|
1999-12-17 |
2006-04-25 |
Amgen Inc. |
Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases
|
|
AU2001257002A1
(en)
*
|
2000-04-10 |
2001-10-23 |
Cubist Pharmaceuticals, Inc. |
Positive selection method, compounds, host cells and uses thereof
|
|
US7625756B2
(en)
*
|
2000-06-28 |
2009-12-01 |
GycoFi, Inc. |
Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells
|
|
US8697394B2
(en)
*
|
2000-06-28 |
2014-04-15 |
Glycofi, Inc. |
Production of modified glycoproteins having multiple antennary structures
|
|
US7863020B2
(en)
*
|
2000-06-28 |
2011-01-04 |
Glycofi, Inc. |
Production of sialylated N-glycans in lower eukaryotes
|
|
PT1522590E
(pt)
|
2000-06-28 |
2009-10-26 |
Glycofi Inc |
Métodos para a produção de glicoproteínas modificadas
|
|
US7449308B2
(en)
|
2000-06-28 |
2008-11-11 |
Glycofi, Inc. |
Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
|
|
US7598055B2
(en)
*
|
2000-06-28 |
2009-10-06 |
Glycofi, Inc. |
N-acetylglucosaminyltransferase III expression in lower eukaryotes
|
|
PT1294910E
(pt)
|
2000-06-30 |
2009-02-16 |
Vib Vzw |
Modificação da glicosilação de proteínas em pichia pastoris
|
|
IL161988A0
(en)
|
2001-11-16 |
2005-11-20 |
Corporation Idec Pharmaceutica |
Polycistronic expression of antibodies
|
|
US7252933B2
(en)
|
2002-06-26 |
2007-08-07 |
Flanders Interuniversity Institute For Biotechnology |
Protein glycosylation modification in methylotrophic yeast
|
|
ATE494367T1
(de)
*
|
2002-12-18 |
2011-01-15 |
Hoffmann La Roche |
Rekombinante desoxyribonuclease i aus rinder- pankreas mit hoher spezifischer aktivität
|
|
ATE387494T1
(de)
*
|
2002-12-20 |
2008-03-15 |
Hoffmann La Roche |
Hitzelabile desoxyribonuklease i-varianten
|
|
US7332299B2
(en)
*
|
2003-02-20 |
2008-02-19 |
Glycofi, Inc. |
Endomannosidases in the modification of glycoproteins in eukaryotes
|
|
EP1460425A1
(en)
*
|
2003-03-17 |
2004-09-22 |
Boehringer Mannheim Gmbh |
Deglycosylated enzymes for conjugates
|
|
ES2337684T3
(es)
*
|
2003-12-05 |
2010-04-28 |
F. Hoffmann-La Roche Ag |
Carboxipeptidasa b recombinante y su purificacion.
|
|
US7588745B2
(en)
*
|
2004-04-13 |
2009-09-15 |
Si Options, Llc |
Silicon-containing products
|
|
EP1926749B1
(en)
*
|
2005-09-14 |
2011-07-27 |
Sanofi-Aventis Deutschland GmbH |
Cleavage of precursors of insulins by a variant of trypsin
|
|
US8741633B2
(en)
*
|
2006-05-19 |
2014-06-03 |
Glycofi, Inc. |
Recombinant vectors
|
|
PT2193196T
(pt)
|
2007-09-28 |
2016-10-24 |
Portola Pharm Inc |
Antídotos para inibidores do fator xa e métodos de utilização dos mesmos
|
|
US8067339B2
(en)
|
2008-07-09 |
2011-11-29 |
Merck Sharp & Dohme Corp. |
Surface display of whole antibodies in eukaryotes
|
|
JP2011530311A
(ja)
|
2008-08-12 |
2011-12-22 |
グライコフィ, インコーポレイテッド |
タンパク質製造のための改良されたベクターおよび酵母株:Ca2+ATPアーゼ過剰発現
|
|
HUE035168T2
(en)
|
2008-09-26 |
2018-05-02 |
Ambrx Inc |
Modified animal erythropoietin polypeptides and their applications
|
|
DK3604510T3
(da)
|
2009-03-30 |
2025-06-30 |
Alexion Pharma Inc |
Antidoter til faktor-Xa-hæmmere og fremgangsmåder til anvendelse deraf
|
|
CN102625712B
(zh)
|
2009-07-15 |
2017-07-25 |
博尔托拉制药公司 |
用于因子xa抑制剂的解毒剂的单位剂量制剂及其使用方法
|
|
EP2488657B1
(en)
|
2009-10-16 |
2016-07-06 |
Merck Sharp & Dohme Corp. |
Method for producing proteins in pichia pastoris that lack detectable cross binding activity to antibodies against host cell antigens
|
|
JP2013509180A
(ja)
|
2009-10-30 |
2013-03-14 |
メルク・シャープ・エンド・ドーム・コーポレイション |
改善された分泌効率を有する組換えタンパク質の産生方法
|
|
AU2011220878A1
(en)
|
2010-02-24 |
2012-08-23 |
Merck Sharp & Dohme Corp. |
Method for increasing N-glycosylation site occupancy on therapeutic glycoproteins produced in Pichia pastoris
|
|
CA2837000C
(en)
|
2011-05-20 |
2021-09-14 |
Alderbio Holdings Llc |
High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as pichia pastoris
|
|
BR112014003841B1
(pt)
|
2011-08-19 |
2022-02-15 |
H. Lundbeck A/S |
Método para identificar uma célula hospedeira diploide de pichia pastoris que produz um anticorpo desejado com uma maior pureza
|
|
CN104254603A
(zh)
|
2012-02-14 |
2014-12-31 |
博尔托拉制药公司 |
用于制备xa因子抑制剂的重组解毒剂的方法
|
|
US9707276B2
(en)
|
2012-12-03 |
2017-07-18 |
Merck Sharp & Dohme Corp. |
O-glycosylated carboxy terminal portion (CTP) peptide-based insulin and insulin analogues
|
|
US9944689B2
(en)
|
2013-03-07 |
2018-04-17 |
The General Hospital Corporation |
Human CTLA4 mutants and use thereof
|
|
ES2834113T3
(es)
|
2013-03-15 |
2021-06-16 |
H Lundbeck As |
Purificación de anticuerpos y monitorización de la pureza
|
|
CN105121652B
(zh)
|
2013-03-15 |
2020-07-28 |
奥尔德生物制药公司 |
用于在酵母和其它转化细胞中高产量表达多肽的温度变动法
|
|
ES2938048T3
(es)
|
2013-07-24 |
2023-04-04 |
Streck Llc |
Composiciones y procedimientos para estabilizar las células tumorales circulantes
|
|
US11168351B2
(en)
|
2015-03-05 |
2021-11-09 |
Streck, Inc. |
Stabilization of nucleic acids in urine
|
|
WO2017011275A1
(en)
|
2015-07-10 |
2017-01-19 |
Nersissian Aram M |
Factor viii protein compositions and methods of treating hemophilia a
|
|
ES3008383T3
(en)
|
2015-10-09 |
2025-03-24 |
Genzyme Corp |
Improved flare (flow cytometry attenuated reporter expression) technology for rapid bulk sorting
|
|
US20170145475A1
(en)
|
2015-11-20 |
2017-05-25 |
Streck, Inc. |
Single spin process for blood plasma separation and plasma composition including preservative
|
|
WO2018022991A1
(en)
|
2016-07-29 |
2018-02-01 |
Streck, Inc. |
Suspension composition for hematology analysis control
|
|
AU2017341028B2
(en)
|
2016-10-07 |
2023-12-21 |
Genzyme Corporation |
Early post-transfection isolation of cells (EPIC) for biologics production
|
|
JP7293244B2
(ja)
|
2017-10-19 |
2023-06-19 |
ストレック, インコーポレイテッド |
溶血、凝固調節および細胞外小胞の安定化のための組成物
|
|
EP3505181B1
(en)
|
2017-12-28 |
2021-07-07 |
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center |
Preparation of enzyme replacement therapy for mucopolysaccharidosis iiid
|
|
US12421316B2
(en)
|
2019-02-19 |
2025-09-23 |
The Regents Of The University Of Colorado, A Body Corporate |
Bispecific immunotoxins targeting human CD25+CCR4+ tumors and regulatory T-cells
|
|
PL4010379T3
(pl)
|
2019-08-08 |
2025-07-28 |
Alexion Pharmaceuticals, Inc. |
Kompozycje i sposoby wytwarzania czynnika xa i pochodnych
|
|
NL2031833B1
(en)
|
2022-05-11 |
2023-11-17 |
Univ Leiden |
Immunotherapeutic compositions and adjuvants
|
|
US20260042998A1
(en)
|
2022-08-11 |
2026-02-12 |
Vib Vzw |
Glyco-Engineered Yeast for Therapeutic Protein Production
|
|
WO2025196308A1
(en)
|
2024-03-22 |
2025-09-25 |
Vib Vzw |
Means and methods for displaying fc-containing proteins on cells and selection thereof
|